Ambulatory Surgical Centers Market to hit USD 144.5 billion by 2032, says Global Market Insights Inc.
09. November 2022 05:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 09, 2022 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market value is estimated to exceed USD 144.5 billion by 2032, according to a new research report by Global...
NasoNeb is now a Division of Monaghan Medical Corporation
16. Juni 2022 10:00 ET
|
NasoNeb, Inc.
PLATTSBURGH, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation (“Monaghan Medical”) in Plattsburgh, New York. Monaghan...
Otonomy to Host Virtual Investor R&D Event on March 22, 2022
25. Februar 2022 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
25. Januar 2022 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
NasoNeb Welcomes Leading Otolaryngologists to Medical Advisory Board
28. Oktober 2021 10:09 ET
|
NasoNeb, Inc.
PLATTSBURGH, N.Y., Oct. 28, 2021 (GLOBE NEWSWIRE) -- NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr....
Ambulatory Surgical Centers Market 2021: Top Three Trends Driving the Global Industry Revenue by 2027: Global Market Insights Inc.
04. Oktober 2021 06:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market size is anticipated to record a valuation of USD 117 billion by 2027, according to the most recent...
Otonomy Announces Presentation of OTO-413 Clinical Results at AAO-HNS Annual Meeting
27. September 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting
05. April 2021 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
06. Februar 2019 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as "Hot Topic"
30. Oktober 2018 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple...